Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evidence for a role of type I interferons in the pathogenesis of dermatomyositis.

× No keyword cloud information.

11 in total

1. Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.

Authors: Ronan J Walsh; Sek Won Kong; Yihong Yao; Bahija Jallal; Peter A Kiener; Jack L Pinkus; Alan H Beggs; Anthony A Amato; Steven A Greenberg
Journal: Arthritis Rheum Date: 2007-11

2. Quinacrine Suppresses Tumor Necrosis Factor-α and IFN-α in Dermatomyositis and Cutaneous Lupus Erythematosus.

Authors: Paul Alves; Muhammad M Bashir; Maria Wysocka; Majid Zeidi; Rui Feng; Victoria P Werth
Journal: J Investig Dermatol Symp Proc Date: 2017-10

Review 3. The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.

Authors: Angela Ceribelli; Maria De Santis; Natasa Isailovic; M Eric Gershwin; Carlo Selmi
Journal: Clin Rev Allergy Immunol Date: 2017-02 Impact factor: 8.667

4. Cutaneous Connective Tissue Diseases: Epidemiology, Diagnosis, and Treatment.

Authors: Bobby Y Reddy; Basil M Hantash
Journal: Open Dermatol J Date: 2009-01-01

5. Severe dermatomyositis triggered by interferon beta-1a therapy and associated with enhanced type I interferon signaling.

Authors: Ally-Khan Somani; Alan R Swick; Kevin D Cooper; Thomas S McCormick
Journal: Arch Dermatol Date: 2008-10

6. Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations.

Authors: Josef Symon S Concha; Aikaterini Patsatsi; Ann Marshak-Rothstein; Ming-Lin Liu; Animesh A Sinha; Lela A Lee; Joseph F Merola; Ali Jabbari; Johann E Gudjonsson; François Chasset; Paul Jarrett; Benjamin Chong; Lisa Arkin; Anthony P Fernandez; Marzia Caproni; Steven A Greenberg; Hee Joo Kim; David R Pearson; Alisa Femia; Ruth Ann Vleugels; David Fiorentino; Manabu Fujimoto; Joerg Wenzel; Victoria P Werth
Journal: J Invest Dermatol Date: 2018-09-19 Impact factor: 8.551

7. Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases.

Authors: David Wong; Bory Kea; Rob Pesich; Brandon W Higgs; Wei Zhu; Patrick Brown; Yihong Yao; David Fiorentino
Journal: PLoS One Date: 2012-01-03 Impact factor: 3.240

8. Gottron's papules exhibit dermal accumulation of CD44 variant 7 (CD44v7) and its binding partner osteopontin: a unique molecular signature.

Authors: Jessica S Kim; Muhammad M Bashir; Victoria P Werth
Journal: J Invest Dermatol Date: 2012-03-29 Impact factor: 8.551

Review 9. Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.

Authors: Thorsten Hornung; Joerg Wenzel
Journal: Drugs Date: 2014-06 Impact factor: 11.431

10. Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis.

Authors: Qing-Lin Peng; Xiao-Ming Shu; Xiao-Lan Tian; Xin Lu; Guo-Chun Wang
Journal: Arthritis Res Ther Date: 2014-01-27 Impact factor: 5.156